PSMAddition: Lu-PSMA in mHSPC
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
February 10, 2022
End Date
December 31, 2027
Administered By
Duke Cancer Institute
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
February 10, 2022
End Date
December 31, 2027